FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

American Health Packaging Nitrofurantoin Capsules Recall

Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100-count Unit Dose Bl…

AMERICAN HEALTH PACKAGING · Columbus, OH

Risk level
Class III
Reported by FDA
Nov 28, 2018
Recall ID
D-0273-2019
Check your lot numberHow we source this data

Summary

American Health Packaging recalled Nitrofurantoin Capsules starting Nov 9, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0273-2019 on Nov 28, 2018. Reason: Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that "These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation.". Status: Terminated.

Why it was recalled

Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that "These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation."

Product description

Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100-count Unit Dose Blisters, Rx only, Amerisource Health Services DBA American Health Packaging, 2550-A John Glenn Avenue Columbus, OH 43217, NDC 68084-446-01 (Individual Dose NDC: 68064-446-11)

Lot numbers, UPCs & expiration codes

Lot#: 180310, 180612, Exp 03/31/20

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0273-2019
Classification
Class III
Status
Terminated
Recall initiated
Nov 9, 2018
FDA report date
Nov 28, 2018
Quantity
4508 blister packs
Recall type
Voluntary: Firm initiated
Recalling firm
AMERICAN HEALTH PACKAGING

Original FDA data

Every field from FDA enforcement report D-0273-2019, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
81553
Address
2550 John Glenn Ave Ste A
Code information
Lot#: 180310, 180612, Exp 03/31/20
Postal code
43217-1188
Report date
Nov 28, 2018
Product type
Drugs
Recall number
D-0273-2019
Classification
Class III
Recalling firm
AMERICAN HEALTH PACKAGING
Product quantity
4508 blister packs
Termination date
Sep 30, 2020
Reason for recall
Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that "These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation."
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100-count Unit Dose Blisters, Rx only, Amerisource Health Services DBA American Health Packaging, 2550-A John Glenn Avenue Columbus, OH 43217, NDC 68084-446-01 (Individual Dose NDC: 68064-446-11)
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Nov 9, 2018
Initial firm notification
Letter
Center classification date
Nov 20, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0273-2019, published Nov 28, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls